Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregnenolone for Cognitive and Negative Symptoms in Schizophrenia
NCT00728728Phase 2Completed
- Sponsor
- VA Office of Research & Development
- Start
- Dec 2009
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pregnenolone in schizophrenia, schizoaffective disorder, sponsored by VA Office of Research & Development. Started Dec 2009; status: completed.
02
Drugs
pregnenolone
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT00728728.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00728728.